1. Home
  2. HIHO vs PPBT Comparison

HIHO vs PPBT Comparison

Compare HIHO & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

HOLD

Current Price

$0.89

Market Cap

4.1M

Sector

Industrials

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$1.50

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIHO
PPBT
Founded
1990
2010
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
2.4M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
HIHO
PPBT
Price
$0.89
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $30.00
AVG Volume (30 Days)
32.3K
★ 2.1M
Earning Date
03-02-2026
05-20-2026
Dividend Yield
★ 14.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.41
52 Week High
$2.21
$5.18

Technical Indicators

Market Signals
Indicator
HIHO
PPBT
Relative Strength Index (RSI) 48.95 41.84
Support Level $0.86 $1.39
Resistance Level $0.93 $1.85
Average True Range (ATR) 0.05 0.16
MACD 0.01 -0.03
Stochastic Oscillator 41.12 27.36

Price Performance

Historical Comparison
HIHO
PPBT

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: